The RCPE GmbH provides independent research and development in pharmaceutical engineering. Funded for 7 years with a total volume of approximately €30 million, the RCPE bridges the gap between science and industrial applications. Located in Graz, Austria, the RCPE is owned by research institutions and funds projects through public and industry partnerships. The RCPE works on various topics including simulation, particle technology, bioprocessing, and quality by design with the goal of cooperation between academia and industry.
1. The document discusses the concepts of genes, genetic code, and genetic control. It describes how genes carry coded information and how one gene corresponds to one enzyme.
2. The genetic code is explained, including how it is read in triplets and is universal. The central dogma of DNA to RNA to protein is also summarized.
3. Gene expression and the lac operon model of genetic regulation are introduced, where operons contain structural genes that are coregulated.
What is innovation? Answers for academic researchersSabina Passamonti
If
· You work in a Region with:
o Highly developed academic system
o Poorly developed links with industries
o Small-sized industries
· You are a researcher needing to direct research activities into the innovation process,
· You are an entrepreneur needing to use academic research reselts for you company development,
· You want to access Research & Innovation funds from Horizon 2020 or Cohesion Policy
So
Read this Columbus egg guide.
The document discusses the Open PHACTS platform, which aims to reduce barriers to drug discovery by integrating pharmacological data from multiple sources into a single API. The platform uses semantic technologies to flexibly integrate datasets and allow adaptive querying. It provides tools and services to support pharmacological research for industry, academia, and small businesses.
Frank PIller: Service Providers Supporting Open InnovationFrank Piller
The document discusses innovation services and the market for open innovation. It provides background on the RWTH Technology & Innovation Management Group, including details on its size, research areas, funding, and partnerships. It then discusses open innovation and how intermediaries are playing a central role in connecting organizations with problems to external solvers through platforms like InnoCentive.
Zoltun Design. We Listen. We Interpret. We Create.Jane Zoltun
Zoltun has been home to expert graphic designers since 1990. We can help your business grow. For more information about our team and process visit www.zoltun.com
Thesis "The role of communication in internationalization processes of RTOs"Ainara Alonso Silva
Master thesis "The role of communication in internationalization processes of RTOs (Research and Technology Organizations): A comparison study between Wageningen University and Research Center and Tecnalia
This document contains examples of creative works from various companies and organizations between 2009-present, including:
- Posters, flyers, ecards, banner stands from Bayard advertising agency for Sports Authority and Vail Resorts
- A postcard, brochure, and fact sheets from Disney Cruise Line
- Websites for officers and crew from Disney Cruise Line
- Job postings and descriptions from Pfizer's Oncology Research team focusing on cancer research and drug discovery
The RCPE GmbH provides independent research and development in pharmaceutical engineering. Funded for 7 years with a total volume of approximately €30 million, the RCPE bridges the gap between science and industrial applications. Located in Graz, Austria, the RCPE is owned by research institutions and funds projects through public and industry partnerships. The RCPE works on various topics including simulation, particle technology, bioprocessing, and quality by design with the goal of cooperation between academia and industry.
1. The document discusses the concepts of genes, genetic code, and genetic control. It describes how genes carry coded information and how one gene corresponds to one enzyme.
2. The genetic code is explained, including how it is read in triplets and is universal. The central dogma of DNA to RNA to protein is also summarized.
3. Gene expression and the lac operon model of genetic regulation are introduced, where operons contain structural genes that are coregulated.
What is innovation? Answers for academic researchersSabina Passamonti
If
· You work in a Region with:
o Highly developed academic system
o Poorly developed links with industries
o Small-sized industries
· You are a researcher needing to direct research activities into the innovation process,
· You are an entrepreneur needing to use academic research reselts for you company development,
· You want to access Research & Innovation funds from Horizon 2020 or Cohesion Policy
So
Read this Columbus egg guide.
The document discusses the Open PHACTS platform, which aims to reduce barriers to drug discovery by integrating pharmacological data from multiple sources into a single API. The platform uses semantic technologies to flexibly integrate datasets and allow adaptive querying. It provides tools and services to support pharmacological research for industry, academia, and small businesses.
Frank PIller: Service Providers Supporting Open InnovationFrank Piller
The document discusses innovation services and the market for open innovation. It provides background on the RWTH Technology & Innovation Management Group, including details on its size, research areas, funding, and partnerships. It then discusses open innovation and how intermediaries are playing a central role in connecting organizations with problems to external solvers through platforms like InnoCentive.
Zoltun Design. We Listen. We Interpret. We Create.Jane Zoltun
Zoltun has been home to expert graphic designers since 1990. We can help your business grow. For more information about our team and process visit www.zoltun.com
Thesis "The role of communication in internationalization processes of RTOs"Ainara Alonso Silva
Master thesis "The role of communication in internationalization processes of RTOs (Research and Technology Organizations): A comparison study between Wageningen University and Research Center and Tecnalia
This document contains examples of creative works from various companies and organizations between 2009-present, including:
- Posters, flyers, ecards, banner stands from Bayard advertising agency for Sports Authority and Vail Resorts
- A postcard, brochure, and fact sheets from Disney Cruise Line
- Websites for officers and crew from Disney Cruise Line
- Job postings and descriptions from Pfizer's Oncology Research team focusing on cancer research and drug discovery
The document provides creative examples from various advertising campaigns and companies. Some of the examples included are recruitment cards, posters, flyers, ecards, banner stands, brochures, fact sheets, microsites, websites, postcards, trade show booths, and television commercials. The campaigns shown are for companies such as Sports Authority, Vail Resorts, Disney Cruise Line, Pfizer, Anheuser-Busch, JPMorgan Chase, Aspen Dental, and Central Florida Health Alliance.
The document discusses a scenario study conducted by SURF, an organization that promotes ICT innovation for higher education and research. [1] The study involved developing four future scenarios for the virtual learning and working environment in Dutch higher education in 2020. [2] Using the scenario method, over 300 people from higher education institutions helped identify key trends and develop the scenarios. [3] The scenarios explore different possibilities for how curriculum, technology use, and the roles of students and teachers may evolve.
This document summarizes the research topics and laboratories of the School of Computer Science at FDU, led by Professor Xiangyang Xue. The school's research includes natural language processing, multimodal dialogue, image classification, and cross-media search. Key laboratories study intelligent media computing, databases, software engineering, and information security. Application areas mentioned include interactive TV, education/gaming robots, and assistant technologies for future smart homes.
SINTEF is the largest independent research organization in Scandinavia. It has 2100 employees from 67 countries working on contracts for customers in over 60 countries. SINTEF's vision is using technology to create a better society by applying knowledge and innovation to deliver sustainable solutions. It works closely with universities and industry on over 7000 projects annually while maintaining high ethical standards. SINTEF is a major participant in European research programs and has world-leading expertise in fields like energy, materials, and medical technology.
Vicente Traver is the general manager of ITACA-TSB, a research group within the Universidad Politécnica de Valencia focused on technologies for health and wellbeing. The group has 30 people working on EU and national research projects involving e-health and e-inclusion using technologies like wireless communication, knowledge management, and ambient intelligence. Vicente Traver is in Tromso, Norway from June to September to learn about their telemedicine model, analyze communication networks and standards, and conduct research on personal health and health 2.0 technologies.
The SAFE II Project aimed to enhance sexual and reproductive health and rights (SRHR) for youth across Europe through better cooperation among EU countries. The project had five implementation packages focused on policy guidance, qualitative research, good practices, stakeholder involvement, and youth participation. Partners in different countries led activities like advocating for policy changes, conducting research, implementing youth-friendly services, engaging stakeholders, and empowering youth. The goal was to promote rights-based approaches, understand youth needs, improve access to SRHR services and information, and increase commitment to supporting youth SRHR.
Engineering expertise is key to boosting the competitiveness of biotechnology companies. PRODINTEC provides technical support from invention to market, including product design, engineering, prototyping, and manufacturing. With facilities for 3D modeling, rapid prototyping, and equipment for precision machining, PRODINTEC helps biotech innovations reach commercialization.
Sixteen Technology Commercialisation Projects receive S$4 million Proof-of-Co...James Chan
• 16 projects receive up to S$250,000 each in this second POC grant call,
• 2 projects came from the polytechnics
• Awarded projects are in the areas of engineering, info-comm technologies,
and life sciences.
Image and modelling for optimized translational research 2011Torben Haagh
Tool Box - Preclinical To Clinical Translation
More details can be found on: http://www.clinical-translation.de/web
Innovative methods and technologies for enhanced imaging, modelling and predictive toxicology
Preclinical to Clinical Translation - New findings on effective and safe transition from the preclinical to the clinical phase!
New efforts are needed to improve the ensemble of methods for ensuring safety and efficacy and increasing the chances of R & D to culminate in a marketable drug. And performing quality preclinical investigation is a prerequisite for reaching a decision whether to move forward towards the first-in-man study and enter phase ‘0’ of the clinical trial or not.
Der Übergang von der präklinischen zur klinischen Phase ist der entscheidende Zeitpunkt im Verlauf der Drug-Discovery. Denn noch immer scheitern 80 % der Versuche, ein Medikament zu first-in-man-studies voranzubringen. Daher wird sich die Konferenz sowohl auf diese Problematik als auch auf die vorhandenen Lösungenen im Markt konzentrieren. So wird den Teilnehmern ein breites Spektrum von Voträgen geboten, ausgehend von Einsatz innovativer Technologien im Bereich Imaging und Modelling bis hin zum intelligenten Daten Management. Entdecken Sie gemeinsam mit marktführenden Pharmaunternehmen das ideale „Werkzeug“ für erfolgsversprechende Translation!
Weiteres finden Sie auf: http://www.clinical-translation.de/web
Keywords: drug discovery, clinical trial, PBPK, PK/PD, toxicology, preclinical, clinical, translation, research, trial
Lecture 10 - Innovation studies and technology policyUNU.MERIT
This document discusses innovation policy, providing definitions and discussing trends over time. It covers the main objectives of innovation policy as promoting new products, services, and processes in markets and organizations. Innovation policy aims to impact economic performance and social cohesion. The document also outlines various policy instruments and trends in innovation policy from the 1960s to the 1990s, including a shift towards an innovation-driven economy.
The document provides information about the ICIC 2012 conference taking place from October 14-17, 2012 in Berlin, Germany. It discusses the topics that will be covered at the conference including patent information retrieval, chemical information, and information technology trends. The conference will include presentations, panels, networking opportunities, and an exhibition with approximately 25 exhibitor stands. It also provides the schedule of events and presentations as well as information on accommodations and social events including a welcome reception and conference dinner.
RESEARCH, DEVELOPMENT & INNOVATION IN TRAN2CARE (Sabina Passamonti University...Sabina Passamonti
The document summarizes the Transregional Network for Innovation and Technology Transfer to Improve Health Care project. The project aimed to create a cross-border network of institutions in Italy and Slovenia dedicated to developing new protocols and biotechnological devices for disease prevention, diagnosis, and treatment. Over three years, the project involved 13 partner institutions, recruited 14 researchers, conducted technology transfers and trainings, mapped intellectual property and research assets, and suggested strategies to attract industries and further innovate healthcare. The network aims to strengthen the region's biomedical sector through open collaboration between clinicians, scientists, and technologists.
This document provides information about the "CNS Clinical Trials" conference taking place on September 16-17, 2010 in London. The conference will examine strategies for successful CNS drug development and overcoming challenges in clinical trial design, management, and recruitment. Key topics will include novel cognitive assessment methods, advances in neuroimaging, adaptive trial design, and the use of biomarkers to demonstrate early drug effects in CNS trials. Speakers will include representatives from pharmaceutical and biotechnology companies as well as academic institutions. Attendees will gain insights on improving various aspects of CNS clinical trials from development through regulatory approval. The conference also provides sponsorship and exhibition opportunities for companies to promote their products and services.
The document provides an overview of the PARENIS project, which aims to advance research capabilities in partner countries. It outlines the project objectives, consortium, priorities, and two phases. The first phase involves research methodology courses for students, while the second establishes mechanisms for university-industry collaboration, including workshops, innovation labs, and research exploitation offices. Key dates and contact details are also included.
This document discusses technology transfer in the pharmaceutical industry. It provides an introduction and definitions of technology transfer. It describes the types of technology, content, steps involved, functions of technology transfer teams, and factors affecting technology transfer. Examples of technology transfer and institutes in India assisting with technology transfer are also mentioned. The key points are that technology transfer refers to transferring scientific findings from research to production and quality assurance, and it is important for commercializing new drugs and maintaining product quality.
The document discusses the Dutch approach to technology transfer and commercialization of research through the Netherlands Genomics Initiative, which developed a strategy involving research centers collaborating with universities and companies, a network of technology transfer offices, and a national life sciences start-up program called LifeSciences@Work to support over 125 projects and companies.
The document discusses developing inexpensive solutions for monitoring C-reactive protein (CRP) levels using printing technology. VTT Technical Research Centre of Finland, University of Turku, and Åbo Akademi University are working with an industrial partner, Orion Diagnostica Oy, to research and develop affordable CRP sensors printed on paper or plastic substrates. The goal is to create easy-to-use and low-cost testing alternatives to standard CRP immunoassays through printing methods like coating and using detection techniques such as capacitive sensors.
This document provides details about a master's thesis project that aims to understand how startups utilize innovative materials and technologies to disrupt the orthopedic implants market. The thesis will analyze market dynamics, trends in materials used for implants, and advances in manufacturing processes. Key criteria for evaluating startups' potential for investment will be identified. The thesis was completed as part of an MSc in Global Management from Antwerp Management School.
This document provides information about opportunities for engagement between the University of Manchester and Colombian partners during a UK science and innovation delegation trip to Colombia from April 16-20, 2012. It highlights Manchester's strengths in research funding and rankings, campus development, Nobel laureates, and research centers. It also profiles Manchester's international research partnerships and graduate business programs. The document promotes horizon scanning tools and services available from the University. Finally, it advertises an upcoming foresight training course in the UK and provides registration details.
The document provides creative examples from various advertising campaigns and companies. Some of the examples included are recruitment cards, posters, flyers, ecards, banner stands, brochures, fact sheets, microsites, websites, postcards, trade show booths, and television commercials. The campaigns shown are for companies such as Sports Authority, Vail Resorts, Disney Cruise Line, Pfizer, Anheuser-Busch, JPMorgan Chase, Aspen Dental, and Central Florida Health Alliance.
The document discusses a scenario study conducted by SURF, an organization that promotes ICT innovation for higher education and research. [1] The study involved developing four future scenarios for the virtual learning and working environment in Dutch higher education in 2020. [2] Using the scenario method, over 300 people from higher education institutions helped identify key trends and develop the scenarios. [3] The scenarios explore different possibilities for how curriculum, technology use, and the roles of students and teachers may evolve.
This document summarizes the research topics and laboratories of the School of Computer Science at FDU, led by Professor Xiangyang Xue. The school's research includes natural language processing, multimodal dialogue, image classification, and cross-media search. Key laboratories study intelligent media computing, databases, software engineering, and information security. Application areas mentioned include interactive TV, education/gaming robots, and assistant technologies for future smart homes.
SINTEF is the largest independent research organization in Scandinavia. It has 2100 employees from 67 countries working on contracts for customers in over 60 countries. SINTEF's vision is using technology to create a better society by applying knowledge and innovation to deliver sustainable solutions. It works closely with universities and industry on over 7000 projects annually while maintaining high ethical standards. SINTEF is a major participant in European research programs and has world-leading expertise in fields like energy, materials, and medical technology.
Vicente Traver is the general manager of ITACA-TSB, a research group within the Universidad Politécnica de Valencia focused on technologies for health and wellbeing. The group has 30 people working on EU and national research projects involving e-health and e-inclusion using technologies like wireless communication, knowledge management, and ambient intelligence. Vicente Traver is in Tromso, Norway from June to September to learn about their telemedicine model, analyze communication networks and standards, and conduct research on personal health and health 2.0 technologies.
The SAFE II Project aimed to enhance sexual and reproductive health and rights (SRHR) for youth across Europe through better cooperation among EU countries. The project had five implementation packages focused on policy guidance, qualitative research, good practices, stakeholder involvement, and youth participation. Partners in different countries led activities like advocating for policy changes, conducting research, implementing youth-friendly services, engaging stakeholders, and empowering youth. The goal was to promote rights-based approaches, understand youth needs, improve access to SRHR services and information, and increase commitment to supporting youth SRHR.
Engineering expertise is key to boosting the competitiveness of biotechnology companies. PRODINTEC provides technical support from invention to market, including product design, engineering, prototyping, and manufacturing. With facilities for 3D modeling, rapid prototyping, and equipment for precision machining, PRODINTEC helps biotech innovations reach commercialization.
Sixteen Technology Commercialisation Projects receive S$4 million Proof-of-Co...James Chan
• 16 projects receive up to S$250,000 each in this second POC grant call,
• 2 projects came from the polytechnics
• Awarded projects are in the areas of engineering, info-comm technologies,
and life sciences.
Image and modelling for optimized translational research 2011Torben Haagh
Tool Box - Preclinical To Clinical Translation
More details can be found on: http://www.clinical-translation.de/web
Innovative methods and technologies for enhanced imaging, modelling and predictive toxicology
Preclinical to Clinical Translation - New findings on effective and safe transition from the preclinical to the clinical phase!
New efforts are needed to improve the ensemble of methods for ensuring safety and efficacy and increasing the chances of R & D to culminate in a marketable drug. And performing quality preclinical investigation is a prerequisite for reaching a decision whether to move forward towards the first-in-man study and enter phase ‘0’ of the clinical trial or not.
Der Übergang von der präklinischen zur klinischen Phase ist der entscheidende Zeitpunkt im Verlauf der Drug-Discovery. Denn noch immer scheitern 80 % der Versuche, ein Medikament zu first-in-man-studies voranzubringen. Daher wird sich die Konferenz sowohl auf diese Problematik als auch auf die vorhandenen Lösungenen im Markt konzentrieren. So wird den Teilnehmern ein breites Spektrum von Voträgen geboten, ausgehend von Einsatz innovativer Technologien im Bereich Imaging und Modelling bis hin zum intelligenten Daten Management. Entdecken Sie gemeinsam mit marktführenden Pharmaunternehmen das ideale „Werkzeug“ für erfolgsversprechende Translation!
Weiteres finden Sie auf: http://www.clinical-translation.de/web
Keywords: drug discovery, clinical trial, PBPK, PK/PD, toxicology, preclinical, clinical, translation, research, trial
Lecture 10 - Innovation studies and technology policyUNU.MERIT
This document discusses innovation policy, providing definitions and discussing trends over time. It covers the main objectives of innovation policy as promoting new products, services, and processes in markets and organizations. Innovation policy aims to impact economic performance and social cohesion. The document also outlines various policy instruments and trends in innovation policy from the 1960s to the 1990s, including a shift towards an innovation-driven economy.
The document provides information about the ICIC 2012 conference taking place from October 14-17, 2012 in Berlin, Germany. It discusses the topics that will be covered at the conference including patent information retrieval, chemical information, and information technology trends. The conference will include presentations, panels, networking opportunities, and an exhibition with approximately 25 exhibitor stands. It also provides the schedule of events and presentations as well as information on accommodations and social events including a welcome reception and conference dinner.
RESEARCH, DEVELOPMENT & INNOVATION IN TRAN2CARE (Sabina Passamonti University...Sabina Passamonti
The document summarizes the Transregional Network for Innovation and Technology Transfer to Improve Health Care project. The project aimed to create a cross-border network of institutions in Italy and Slovenia dedicated to developing new protocols and biotechnological devices for disease prevention, diagnosis, and treatment. Over three years, the project involved 13 partner institutions, recruited 14 researchers, conducted technology transfers and trainings, mapped intellectual property and research assets, and suggested strategies to attract industries and further innovate healthcare. The network aims to strengthen the region's biomedical sector through open collaboration between clinicians, scientists, and technologists.
This document provides information about the "CNS Clinical Trials" conference taking place on September 16-17, 2010 in London. The conference will examine strategies for successful CNS drug development and overcoming challenges in clinical trial design, management, and recruitment. Key topics will include novel cognitive assessment methods, advances in neuroimaging, adaptive trial design, and the use of biomarkers to demonstrate early drug effects in CNS trials. Speakers will include representatives from pharmaceutical and biotechnology companies as well as academic institutions. Attendees will gain insights on improving various aspects of CNS clinical trials from development through regulatory approval. The conference also provides sponsorship and exhibition opportunities for companies to promote their products and services.
The document provides an overview of the PARENIS project, which aims to advance research capabilities in partner countries. It outlines the project objectives, consortium, priorities, and two phases. The first phase involves research methodology courses for students, while the second establishes mechanisms for university-industry collaboration, including workshops, innovation labs, and research exploitation offices. Key dates and contact details are also included.
This document discusses technology transfer in the pharmaceutical industry. It provides an introduction and definitions of technology transfer. It describes the types of technology, content, steps involved, functions of technology transfer teams, and factors affecting technology transfer. Examples of technology transfer and institutes in India assisting with technology transfer are also mentioned. The key points are that technology transfer refers to transferring scientific findings from research to production and quality assurance, and it is important for commercializing new drugs and maintaining product quality.
The document discusses the Dutch approach to technology transfer and commercialization of research through the Netherlands Genomics Initiative, which developed a strategy involving research centers collaborating with universities and companies, a network of technology transfer offices, and a national life sciences start-up program called LifeSciences@Work to support over 125 projects and companies.
The document discusses developing inexpensive solutions for monitoring C-reactive protein (CRP) levels using printing technology. VTT Technical Research Centre of Finland, University of Turku, and Åbo Akademi University are working with an industrial partner, Orion Diagnostica Oy, to research and develop affordable CRP sensors printed on paper or plastic substrates. The goal is to create easy-to-use and low-cost testing alternatives to standard CRP immunoassays through printing methods like coating and using detection techniques such as capacitive sensors.
This document provides details about a master's thesis project that aims to understand how startups utilize innovative materials and technologies to disrupt the orthopedic implants market. The thesis will analyze market dynamics, trends in materials used for implants, and advances in manufacturing processes. Key criteria for evaluating startups' potential for investment will be identified. The thesis was completed as part of an MSc in Global Management from Antwerp Management School.
This document provides information about opportunities for engagement between the University of Manchester and Colombian partners during a UK science and innovation delegation trip to Colombia from April 16-20, 2012. It highlights Manchester's strengths in research funding and rankings, campus development, Nobel laureates, and research centers. It also profiles Manchester's international research partnerships and graduate business programs. The document promotes horizon scanning tools and services available from the University. Finally, it advertises an upcoming foresight training course in the UK and provides registration details.
Finnish Perspective to the Personalised Medicine while Bridging towards Horiz...
Poster AUTM 2010
1. Technology Transfer at the University of Antwerp, Belgium:
The Industrial Research Fund and the Role of Research & Innovation Managers
VANESSA VANKERCKHOVENA, JURGEN JOOSSENSB , AND PASCALE REDIG C
, JURGEN JOOSSENS , AND PASCALE REDIG
AVaxinfectio (Vaccine & Infectious Disease Institute), BADDN (Antwerp Drug Discovery Network), CTechnology Transfer Office, University of Antwerp, Belgium
(Vaccine & Infectious Institute) ADDN (Antwerp Drug Discovery Network), Transfer Office, University of Antwerp, Belgium
The University of Antwerp (UA) is one of the five Universities located in Flanders, the Flemish region in Belgium. The UA is a knowledge centre employing more than 3.600 co‐workers performing
y p g g g p y g p g 9 RESEARCH CONSORTIA contd
9 RESEARCH CONSORTIA contd
ground‐breaking and innovative research of international standing. The research expenditure for 2008 amounted to 107M€ of which 10% originated from industrial collaborations.
To facilitate collaborations with industrial partners and to investigate opportunities for technology transfer and innovation within the different Research Consortia at UA, Research & Innovation Development and research
managers have been appointed who closely collaborate with the central Technology Transfer Office. To date, 9 Research Consortia, which have been selected based on their research expertise and their UCAG of active compounds in
technology transfer potential, have been assigned a research & innovation manager. medicinal plants
9 RESEARCH CONSORTIA
PROFILE R&I MANAGERS Drug discovery network for
‘hit to lead’ and ‘lead p
Translational platform for
The Research & Innovation managers are Antwerp D
A t Drug optimalisation’
l ’ with
h a Pathophysiology bone technology
postdoctoral fellows that have a strong sense for R&I Research Discovery specific focus on infectious
business development, possess the necessary RIOFI Consortium
Network diseases, oncology, central
communication skills, have (project) management Manager nervous sytem
metabolic disorders
and
experience, have excellent networking skills and Innovative organic synthesis
are competent in attracting external research Organica methodology and VCD
funding. VAXINFECTIO Multidisciplinary platform analysis methods
They have a strong scientific background in the for infectious diseases and
for infectious diseases and
vaccines
research domain of the Consortium and are TASKS R&I MANAGERS
closely involved in the ongoing research projects. Imaging Biomedical imaging
The R&I managers have a large degree of • To offer strategic support in terms of valorisation of the Consortium
operational freedom (including his/her own Applied
research performed within their Consortium Development of technology
budget) and reports directly to the Consortium’s Molecular for molecular genomics
• To assess development of new technologies within their Genomics
Board and the Innovation Board of the University Consortium
(
(RIOFI).
) • To set‐up and maintain industrial and academic partnerships Environmental toxicology
The R&I managers are evaluated on a yearly Environmics and technology for a
• To assess possibilities of tech transfer, including licensing deals, sustainable world
basis and their personal performance indicators patents and spin‐offs, within their Consortium Electron microscopy for
are closely monitored. EMAT
• To apply for external researching funding, such as EU research of materials and
Successful R&I managers will be able to increase framework programmes nanotechnology
research output and internal growth of the • To enhance visibility and output of their Consortium
Consortium with direct benefit for the University.
Contact
Vanessa Vankerckhoven
Vaxinfectio
University of Antwerp
Universiteitsplein 1
BE‐2610 Antwerp (Wilrijk)
E: vanessa.vankerckhoven@ua.ac.be